Grufity logo
Grufity logo
HSDT

HSDT - Helius Medical Technologies Inc Stock Price, Fair Value and News

$2.30+0.08 (+3.60%)
Market Closed as of 14 Sep 2026, 04:00 pm ET

HSDT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

HSDT Price Action

Last 7 days

2.7%

Last 30 days

35.3%

Last 90 days

41.1%

Trailing 12 Months

-69.6%

HSDT RSI Chart

HSDT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

HSDT Valuation

Market Cap

139.1M

Price/Earnings (Trailing)

-0.88

Price/Sales (Trailing)

11.52

EV/EBITDA

-0.86

Price/Free Cashflow

-5.17

HSDT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

HSDT Fundamentals

HSDT Revenue

Revenue (TTM)

12.1M

Rev. Growth (Yr)

5.8K%

Rev. Growth (Qtr)

-30.24%

HSDT Earnings

Earnings (TTM)

-157.3M

Earnings Growth (Yr)

-207.7%

Earnings Growth (Qtr)

69.68%

HSDT Profitability

Operating Margin

95.86%

EBT Margin

-1302.79%

Return on Equity

-94.95%

Return on Assets

-89.33%

Free Cashflow Yield

-19.36%

HSDT Investor Care

Shares Dilution (1Y)

581498.52%

Diluted EPS (TTM)

256.11

Revenue & Growth

How Helius Medical Technologies Inc generates revenue and covers its expenses, based on the latest reported earnings.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
20269.6M12.1M--
2025434.0K295.0K941.0K6.0M
2024668.0K594.0K502.0K520.0K
2023708.0K845.0K792.0K644.0K
2022628.0K676.0K763.0K787.0K
2021538.5K476.5K454.5K522.0K
20201.0M641.5K622.5K661.5K
20191.1M1.6M1.8M1.5M
2018170.2K60.2K63.4K478.0K
2016103.3K120.0K136.8K153.5K
201520.1K-45.1K159.4K
2014----
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Helius Medical Technologies Inc

HSDT
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.
 CEO
 WEBSITEhttps://heliusmedical.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES26

Helius Medical Technologies Inc Frequently Asked Questions

HSDT is the stock ticker symbol of Helius Medical Technologies Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Mon Sep 14 2026, market cap of Helius Medical Technologies Inc is 139.06 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Mon Sep 14 2026, HSDT's PE ratio (Price to Earnings) is -0.88 and Price to Sales (PS) ratio is 11.52. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. HSDT PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Helius Medical Technologies Inc has provided -0.773 (multiply by 100 for percentage) rate of return.